Skip to main content
. 2020 Mar 13;180(3):809–817. doi: 10.1007/s10549-020-05578-6

Fig. 2.

Fig. 2

Oncologists’ recommendation to patients, and subsequent uptake of chemotherapy in patients with a low-risk recurrence score (RS) (< 18); b intermediate-risk RS (18–30); c high-risk RS (> 30)